# Kumaon Turmeric (Curcuma longa)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/kumaon-turmeric
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Curcuma longa, Indian saffron, Kumaoni haldi, Himalayan turmeric, High-altitude turmeric, Kumaon haldi, Uttarakhand turmeric

## Overview

Kumaon Turmeric is a regional variety of Curcuma longa cultivated in the Kumaon Himalayan region of Uttarakhand, India, containing curcuminoids—primarily curcumin—as its principal bioactive compounds. Curcumin exerts antioxidant and [anti-inflammatory](/ingredients/condition/inflammation) effects by inhibiting NF-κB signaling, scavenging [reactive oxygen species](/ingredients/condition/antioxidant), and interfering with amyloid-beta peptide aggregation linked to neurodegeneration.

## Health Benefits

• May support neuroprotection through inhibition of Aβ aggregation and ROS generation (evidence quality: preliminary - general C. longa data only)
• Traditional use suggests [anti-inflammatory](/ingredients/condition/inflammation) properties (evidence quality: traditional use only)
• No specific human clinical trials exist for Kumaon Turmeric as a distinct cultivar
• Contains curcuminoids responsible for bioactivity (evidence quality: chemical analysis only)
• Further research needed to establish cultivar-specific benefits

## Mechanism of Action

Curcumin, the primary polyphenol in Kumaon Turmeric, inhibits the NF-κB transcription factor pathway by blocking IκB kinase (IKK) activation, thereby suppressing downstream [pro-inflammatory cytokine](/ingredients/condition/inflammation)s including TNF-α, IL-1β, and IL-6. It also directly scavenges [reactive oxygen species](/ingredients/condition/antioxidant) (ROS) and upregulates endogenous antioxidant enzymes such as superoxide dismutase (SOD) and heme oxygenase-1 (HO-1) via Nrf2 pathway activation. Additionally, curcumin inhibits the aggregation of amyloid-beta (Aβ) peptides by binding to Aβ monomers and fibrils, a mechanism studied in the context of Alzheimer's disease prevention, though this has not been confirmed in trials specific to the Kumaon cultivar.

## Clinical Summary

No human clinical trials have been conducted specifically on Kumaon Turmeric as a distinct cultivar, making direct evidence for this variety absent. General Curcuma longa and curcumin research provides indirect context: meta-analyses of randomized controlled trials (typically involving 30–120 participants) report statistically significant reductions in CRP and IL-6 with standardized curcumin doses of 500–1500 mg/day over 8–12 weeks. In vitro studies using C. longa-derived curcumin demonstrate inhibition of Aβ1-42 aggregation at concentrations of 1–10 µM, supporting theoretical [neuroprotective](/ingredients/condition/cognitive) potential. The overall evidence base for Kumaon Turmeric specifically remains at the traditional-use and preliminary in vitro level, and extrapolation from general curcumin research should be made cautiously.

## Nutritional Profile

{"macronutrients": {"carbohydrates": "approximately 65-70g per 100g", "protein": "approximately 8g per 100g", "fiber": "approximately 20g per 100g", "fat": "approximately 10g per 100g"}, "micronutrients": {"vitamin_c": "approximately 0.7mg per 100g", "vitamin_b6": "approximately 0.1mg per 100g", "iron": "approximately 55mg per 100g", "potassium": "approximately 2080mg per 100g", "manganese": "approximately 7mg per 100g"}, "bioactive_compounds": {"curcuminoids": "approximately 3-5% of dry weight", "curcumin": "major component of curcuminoids"}, "bioavailability_notes": "Curcuminoids, including curcumin, have low bioavailability, which can be enhanced by co-ingestion with piperine (found in black pepper) or fats."}

## Dosage & Preparation

No clinically studied dosage ranges exist specifically for Kumaon Turmeric. General C. longa studies often use standardized curcumin extracts (95% curcuminoids) at 500-2000 mg/day, but cultivar-specific standardization data is unavailable. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Curcumin from Curcuma longa is generally recognized as safe (GRAS) at culinary doses; supplemental doses up to 8 g/day have been used in short-term trials with mild gastrointestinal side effects such as nausea, bloating, and diarrhea being the most commonly reported adverse events. Curcumin inhibits cytochrome P450 enzymes CYP3A4 and CYP2C9 and may potentiate the effects of anticoagulants such as warfarin, antiplatelet drugs like clopidogrel, and NSAIDs, increasing bleeding risk. Individuals scheduled for surgery are advised to discontinue curcumin supplementation at least two weeks prior due to its antiplatelet activity. Pregnant women should avoid high-dose supplemental curcumin, as it may stimulate uterine contractions, though culinary amounts are considered safe; those with gallstones or bile duct obstruction should also exercise caution due to curcumin's cholagogue effects.

## Scientific Research

No specific human clinical trials, RCTs, or meta-analyses exist for Kumaon Turmeric as a distinct cultivar. General C. longa research shows [neuroprotective effect](/ingredients/condition/cognitive)s through Aβ aggregation inhibition, but no PMIDs or specific study details were identified for this cultivar variant.

## Historical & Cultural Context

Kumaon Turmeric has been used in Ayurvedic and Indian traditional medicine for centuries as a condiment, dye, drug, and cosmetic, known as 'Indian saffron.' It has been cultivated in the Kumaon region for spice production with documented [anti-inflammatory](/ingredients/condition/inflammation) and coloring properties.

## Synergistic Combinations

Black pepper (piperine), ginger, boswellia, quercetin, omega-3 fatty acids

## Frequently Asked Questions

### What makes Kumaon Turmeric different from regular turmeric?

Kumaon Turmeric refers to Curcuma longa grown in the Kumaon hills of Uttarakhand, India, where soil composition, altitude, and climate may influence curcuminoid concentration and volatile oil profile compared to commercially dominant varieties like Alleppey or Madras. However, no peer-reviewed comparative phytochemical studies have been published quantifying curcumin content differences between Kumaon and other C. longa cultivars. Until such data exists, its biochemical profile is assumed to be broadly similar to standard C. longa.

### Can Kumaon Turmeric help with inflammation?

Like other Curcuma longa varieties, Kumaon Turmeric contains curcumin, which suppresses inflammatory pathways by inhibiting NF-κB activation and reducing circulating cytokines such as TNF-α and IL-6. Randomized trials using standardized curcumin extracts (500–1500 mg/day) have shown meaningful reductions in high-sensitivity CRP in populations with metabolic syndrome and osteoarthritis. No trials have tested Kumaon Turmeric specifically, so its anti-inflammatory efficacy is inferred from the general curcumin literature.

### What is the recommended dosage of Kumaon Turmeric supplement?

No dosage has been established specifically for Kumaon Turmeric. Based on curcumin research, supplemental doses studied in clinical trials range from 500 mg to 1500 mg of curcumin per day, often formulated with piperine (black pepper extract, 5–20 mg) or lipid carriers to overcome curcumin's poor oral bioavailability of less than 1% in its unformulated state. Always follow manufacturer guidance and consult a healthcare provider before supplementing, particularly if taking anticoagulant medications.

### Does Kumaon Turmeric support brain health or memory?

Curcumin, the primary bioactive in Kumaon Turmeric, has shown the ability to bind amyloid-beta (Aβ) peptides at micromolar concentrations in vitro, potentially inhibiting the fibril formation associated with Alzheimer's disease pathology. A small 18-month double-blind RCT (n=40) using 90 mg twice-daily bioavailable curcumin reported improved memory scores and reduced amyloid PET signals in older adults without dementia. Kumaon Turmeric has not been independently studied for cognitive outcomes, and these findings from general curcumin research cannot be directly attributed to this cultivar.

### Is Kumaon Turmeric safe to take with blood thinners like warfarin?

Curcumin in Kumaon Turmeric inhibits platelet aggregation and suppresses thromboxane B2 production, mechanisms that can amplify the anticoagulant effect of warfarin (a CYP2C9 substrate) and increase the risk of bleeding. Case reports have documented elevated INR values in patients combining curcumin supplements with warfarin therapy. Anyone taking anticoagulants, antiplatelets, or scheduled for surgery should consult their physician before using any curcumin-containing supplement, including Kumaon Turmeric.

### How does Kumaon Turmeric's curcuminoid content compare to other turmeric cultivars?

Kumaon Turmeric, grown in the Kumaon region of the Himalayas, is traditionally recognized for its high curcuminoid concentration, though no peer-reviewed comparative analysis specifically isolates its curcuminoid levels against other cultivars. Most bioactive effects of turmeric are attributed to curcuminoids, which means higher concentrations may theoretically enhance efficacy, but direct clinical evidence comparing Kumaon to other varieties remains absent. Curcuminoid content can vary significantly based on growing conditions, harvest timing, and processing methods regardless of cultivar.

### Is Kumaon Turmeric safe to use during pregnancy or while breastfeeding?

Limited safety data exists specifically for Kumaon Turmeric in pregnant or nursing populations, as this cultivar has not been subject to dedicated human safety trials. General turmeric supplementation during pregnancy remains controversial—while traditional use suggests safety at culinary doses, high-dose supplementation is often discouraged due to potential uterine stimulation. Consult a healthcare provider before using Kumaon Turmeric supplements during pregnancy or lactation.

### What is the evidence quality for Kumaon Turmeric's neuroprotective effects?

Evidence for Kumaon Turmeric's neuroprotective benefits is currently preliminary and based primarily on general Curcuma longa research rather than cultivar-specific human trials. Laboratory studies suggest curcuminoids may inhibit amyloid-beta aggregation and reduce reactive oxygen species, but these findings have not been confirmed in human clinical trials specifically using Kumaon Turmeric. More rigorous research directly testing this cultivar variant in human subjects is needed to establish efficacy claims.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*